2007–08 | 2010 | |||
No. of cases reported | % NSCLC reported as ‘NOS’ | No. of cases reported | % NSCLC reported as ‘NOS’ | |
Consultant A | 290 | 25.5 | 122 | 6.5 |
Consultant B | 67 | 53.7 | 27 | 0 |
Consultant C | 66 | 47.0 | 33 | 9 |
NOS, not otherwise specified; NSCLC, non-small cell carcinoma.